News

CHDS Deputy Director Lisa Robinson will be a keynote speaker at the upcoming Society for Benefit-Cost Analysis (SBCA) European conference, held in Milan, Italy on September 11-12, 2023.

CHDS faculty Davene Wright received the 2023 Gordon Moore Award for Excellence in Mentoring from the Department of Population Medicine in the Harvard Pilgrim Health Care Institute.

Allison Portnoy, former Vaccine Decision Science Policy Fellow at CHDS, will begin as an assistant professor in the Department of Global Health at the Boston University School of Public Health.

The recently published open-access book, Handbook of Applied Health Economics in Vaccines, provides insights into the complexities of vaccine discovery, financing, and distribution.

John Giardina, doctoral student in Health Policy concentrating in Decision Science, successfully defended his thesis, “Accounting for Heterogeneity in Health Decision Analysis.” Overseen by Ankur Pandya

CHDS faculty Nicole Campos and a team of researchers from the National Cancer Institute, including co-investigators Brian Befano and Li C. Cheung, proposed a resource-efficient

Social welfare functions (SWFs) allow policy evaluations to account explicitly for the distribution of well-being effects in the population, unlike conventional benefit-cost analysis.

The 18th Biennial European Conference of the Society for Medical Decision Making (SMDM) was held in Berlin, Germany and included contributions by CHDS faculty, researchers,

Recent Harvard Chan School MPH graduate Brandon Yan and CHDS faculty Ankur Pandya published a cost-effectiveness analysis of the new 2022 guideline-directed therapy for heart failure with reduced

The monetary value of a reduction in mortality risk is often quantified using one of three concepts: the “value per statistical life” (VSL),“value per statistical life year” (VSLY),